Posted on 4/16/19
Rocket Pharmaceuticals Proposes Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT), a leading U.S.-based multi-platform gene therapy company, today announces that it has commenced an underwritten public offering of shares . . .
Posted on 4/15/19
M Science Partners with Placer.ai
NEW YORK--(BUSINESS WIRE)--M Science, the pioneer in data-driven research and analytics, today launched TRAFFIC, a data solution offering deep visibility into footfall trends. These unique insights . . .
Posted on 4/15/19
Eagle Pharmaceuticals Expands Licensing Agreement for BENDEKA with Teva Pharmaceuticals International GmbH
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that it has expanded its existing BENDEKA licensing agreement with Teva Pharmaceuticals International GmbH. Under the . . .
Posted on 4/15/19
Paragon Biosciences Acquired By Catalent for $1.2 Billion
Catalent, Inc. (NYSE:CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products
Posted on 4/15/19
The 3 Greatest Risks Pfizer Faces
Pfizer (NYSE:PFE) shareholders have plenty of reasons to be optimistic. Shares of the big drugmaker are up 15% over the last 12 months, well above the . . .
Posted on 4/15/19
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
Two of the hottest biotech stocks on the market right now are GW Pharmaceuticals(NASDAQ:GWPH) and Cara Therapeutics (NASDAQ:CARA). Shares of GW have soared more than 70% . . .
Posted on 4/12/19
Cara Therapeutics: Targeting CKD-Associated Pruritus
Summary Cara's KORSUVA is targeting pruritus in CKD patients undergoing dialysis. There are no approved drugs in the US using the MOA of KORSUVA. However, the . . .
Posted on 4/12/19
Trevi Therapeutics Begins IPO Process
Summary Trevi Therapeutics has filed its initial S-1 registration statement for an IPO. The firm is developing treatment candidates for pruritus and other serious conditions. TRVI . . .
Posted on 4/12/19
bluebird bio's CHMP Response Lays Groundwork For Its First Gene Therapy Approval
Summary bluebird bio's Zynteglo receives positive CHMP opinion for approval of Zynteglo to treat transfusion dependent beta-thalassemia patients. The European Commission is expected to make its . . .
Posted on 4/12/19
Celgene And Acceleron: BLA Luspatercept Has Strong Potential
SummaryCelgene announced that it had submitted its BLA to receive FDA approval for luspatercept to treat patients with two diseases that are associated with anemia.If luspatercept . . .
Posted on 4/11/19
Celularity Enters Lease to Develop Advanced Cell Manufacturing and Research Facility
WARREN, N.J.--(BUSINESS WIRE)--Celularity, Inc., a clinical-stage cell therapeutics company developing allogeneic cellular therapies harnessed from human placentas, today announced the Company has entered into a long-term . . .
Posted on 4/11/19
Summit Health Management Partners with Arcadia.io
BERKELEY HEIGHTS, N.J. & BURLINGTON, Mass.--(BUSINESS WIRE)--Summit Health Management (SHM), which offers a physician-led, professionally-managed model of management services for Summit Medical Group in New Jersey . . .
Posted on 4/11/19
Prominent Arkansas Health Plan Partners with Tabula Rasa Healthcare’s PrescribeWellness
MOORESTOWN, N.J. and IRVINE, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of . . .
Posted on 4/11/19
Sprout Health Group Acquires Endeavor House North
Sprout Health Group, a leading network of inpatient and outpatient facilities for treating addiction and co-occurring
Posted on 4/11/19
WallachBeth Capital Announces Completion of the $5 Million IPO for Guardion Health Services
WallachBeth Capital, a leading provider of capital markets and institutional execution services, announced the closing of the initial public offering of 1,250,000 shares of common stock . . .
Posted on 4/11/19
Pharmacy Times Named Industry News Provider of the Year by American Pharmacy Purchasing Alliance
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times, the leading media resource for pharmacists and the pharmacy industry, has been named 2019 Industry News Provider of the Year by the . . .
Posted on 4/11/19
Bristol-Myers Squibb Receives 2019 ENERGY STAR Partner of the Year – Sustained Excellence Award
NEW YORK--(BUSINESS WIRE)--The U.S. Environmental Protection Agency (EPA) has recognized Bristol-Myers Squibb Company (NYSE: BMY) with an ENERGY STAR Partner of the Year Sustained Excellence Award . . .
Posted on 4/11/19
Johnson & Johnson: Solid, Stable Returns, But Pfizer A Better Prospect
SummaryAs of April 5, Johnson & Johnson shares closed at $136.18. The share price has shown fairly steady growth, from ~$70 in 2012 to the current . . .
Posted on 4/11/19
Pfizer: Solid, Stable Returns
SummaryAs of April 5, Pfizer Inc (PFE) shares closed at $42.99.Supported by large share repurchases, Pfizer share price has shown steady growth, from ~$25 in 2012 . . .
Posted on 4/10/19
Outlook Therapeutics Prices Public Offering of Common Stock and Warrants
CRANBURY, N.J., April 10, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) announced today the pricing of an underwritten public offering of 10,340,000 shares of . . .
Posted on 4/10/19
CIT Serves as Sole Lead Arranger of $36.8 Million in Financing for Bakersfield Heart Hospital
CIT Group Inc. (NYSE: CIT) today announced its Healthcare Finance business served as sole lead arranger for $36.8 million in financing for the real estate acquisition . . .
Posted on 4/10/19
Why bluebird bio Could Deliver Miracles to Genetic Disease Patients
Over the course of The Motley Fool's 26-year history, one of its guiding principles has been to look for the positive side of the story. The . . .
Posted on 4/10/19
Why Hain Celestial Group Stock Gained 18% in March
What happenedOrganic and natural foods specialist Hain Celestial Group (NASDAQ:HAIN) outpaced the market last month by rising 18% compared to a 1.8% uptick in the S&P . . .
Posted on 4/9/19
Pharmacy Times and Parata Systems Will Celebrate Outstanding Pharmacy Professionals
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times, the leading media resource for pharmacists, in conjunction with Parata Systems will host the 2019 Next-Generation Pharmacist Awards ceremony and gala on . . .
Posted on 4/9/19
Hoy Health Raises Series Seed Preferred Investment from 3Ríos Group
MORRISTOWN, N.J. & SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Hoy Health LLC today announced that it has completed a multi-million dollar first round of its Series Seed Preferred . . .

